Skip to content

Novavax NVAX Interest coverage

Interest coverage at other companies

Roivant Sciences logo
Roivant SciencesROIV
122.5×+104×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-49.3×-20.0×
ALN
Alnylam PharmaceuticalsALNY
3.4×+2.9×
Gilead Sciences logo
Gilead SciencesGILD
10.3×+2.0×
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-5×-1.1×
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
-5.1×-5.4×

Other financials

Income statement

See full
Revenue$139.5M-79.1%
Gross profit$108.8M-83.3%
Operating income-$15.4M-103%
Net income-$9.5M-102%
EPS (diluted)-$0.06-102%

Balance sheet

See full
Cash & equivalents$228.4M-13.3%
Total debt$295.1M+404%
Total equity-$144.8M-91.4%
Total assets$1.0B-19.3%

Cash flow

See full
Operating cash flow-$32.4M+82.5%
CapEx$1.3M-20.4%
Free cash flow-$33.7M+82.0%

Valuation

See full
Market cap$1.46B+41.0%
Enterprise value$1.53B+83.6%
P/S2.5×+1.6×

Profitability

See full
Gross margin85%-2.5pp
Operating margin-13.1%-45.9pp
Net margin-14.7%-52.9pp
FCF margin-58.9%-61.4pp

Returns & leverage

See full
Return on equity-238.6%
Debt / equity1.5×
Current ratio2.5×+0.4×

Where this comes from

Calculated from Novavax’s reported figures.

Based on trailing twelve months.

The official record: Novavax’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novavax's interest coverage?
Novavax (NVAX) reported interest coverage of -3.6× in Q1 2026.
How has Novavax's interest coverage changed year-over-year?
Novavax's interest coverage decreased by 119.0% year-over-year, from 19× to -3.6×.
What is the long-term trend for Novavax's interest coverage?
Over 5 years (2020 to 2025), Novavax's interest coverage has grown at a -6.1% compound annual growth rate (CAGR), from -27.5× to 20.1×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.